What is CVE-2025-26683?

CVE-2025-26683 is a high-severity vulnerability in Microsoft Azure Playwright, classified under Improper Authorization. CVSS score: 8.1/10. Published 2025-03-31.

How severe is CVE-2025-26683?

High severity. CVSS v3 base score is 8.1 out of 10.

Is CVE-2025-26683 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Auth bypass in Microsoft Azure Playwright

CVE-2025-26683

Improper authorization in Azure Playwright allows an unauthorized attacker to elevate privileges over a network.

Published 2025-03-31 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 8.1 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.007 (50.7th percentile), scored 2026-10-04.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 51st percentile — 50.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: +0.000

Affected products

Weakness classification (CWE)

CWE-285 — Improper Authorization

Public proof-of-concept exploits

ghostbyt3/patch-tuesday

References

Azure Playwright Elevation of Privilege Vulnerability (vendor-advisory, patch, Vendor Advisory)

Frequently asked questions

What is CVE-2025-26683?: CVE-2025-26683 is a high-severity vulnerability in Microsoft Azure Playwright, classified under Improper Authorization. CVSS score: 8.1/10. Published 2025-03-31.
How severe is CVE-2025-26683?: High severity. CVSS v3 base score is 8.1 out of 10.
Is CVE-2025-26683 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.